OptimizeRx Reports First Quarter 2020 Results; Revenue Up 46% to a Record $7.6 Million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Optimizerx Corporation (OPRX) Misses Q1 EPS by 3c, Revenues Beat
May 4, 2020 4:40 PM EDTOptimizerx Corporation (NASDAQ: OPRX) reported Q1 EPS of ($0.06), $0.03 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $7.6 million versus the consensus estimate of $6.89 million.
Q1 2020 Financial Highlights
Total year over year revenue increased 46% to a record $7.6 million.Year over year gross profit increased 20% to $4.3 million.Cash and cash equivalents totaled $15.2 million at March 31, 2020.Q1 2020 Operational Highlights
Secured several multi-million-dollar enterprise-level engagements for access to OptimizeRxs fully integrated communications platform, further transitioning the company to a recurring revenue model. OptimizeRx Innovation Lab launched... More